HealthQuill RSV
British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.
Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.

Read More
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Drugs Health Medical Pharma

GSK gets FDA nod for adult respiratory syncytial virus (RSV) vaccine

GSK races ahead of rivals Pfizer and Moderna in getting FDA approval for RSV vaccine.

Read More
X